Two companies benefitting from the Middle East war
As the share market gyrates around the expected impact of the Iran War, a small group of companies are experiencing a benefit. Here are two more such situations.
James Dunn is a freelance finance journalist and media consultant. James was founding editor of Shares magazine, and formerly, the personal investment editor at The Australian. His first book, Share Investing for Dummies, was published by John Wiley & Co. in September 2002: a second edition was published in March 2007, and a third edition was published in April 2011. There have also been two editions of the mini-version, Getting Started in Shares for Dummies. James is also a regular finance commentator on Australian radio and television: he gives a daily finance report on Radio 3AW in Melbourne and is a weekly commentator on Sky Business.
As the share market gyrates around the expected impact of the Iran War, a small group of companies are experiencing a benefit. Here are two more such situations.
Here are stocks the market appears to think could benefit from the Middle East fiasco. Here are two such cases.
Here are two of the ASX's most promising uranium-mining prospects – both with projects located in Africa, and each with different paths to market – that I think offer good buying, with certain caveats in mind.
Two candidates from the S&P/ASX 100 with strong market leadership positions and beaten-down share prices.
The ever-broadening exchange-traded fund (ETF) market offers some interesting opportunities.
Global defence and security spending has significantly accelerated in recent years in response to the evolving geo-political backdrop. Even if global economies fall into recession, government defence spending is likely to rise. The ASX has three ETFs that combine growth and stability, and here’s a look at them.
This content is only accessible to logged in members. Please login to continue.
Here are two mining services companies that are possibly flying under the radar, that could reward investigation right now.
Here are three promising (though not yet profitable and speculative) companies trying to emulate that success of medical device companies such as Cochlear and RedMed.
Here are three stocks positioned nicely to bring gas to hungry markets. These are unprofitable, speculative stocks – with attractive potential attributes – so, as always, do your own homework!
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.